807 New COVID-19 Cases Since

Wednesday, November 2, 2022

Also:  8 Deaths Reported

County Is Now in Medium Transmission Category

MOHAVE COUNTY, AZ (December 7, 2022) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 807 new confirmed COVID-19 cases reported since Wednesday, November 2, 2022 at noon. Also, 8 deaths are also reported since the last published COVID-19 report. Note that deaths are counted by the week of COVID-19 diagnosis (not date of death) and monthly counts may increase as there is often a lag between when case patient is diagnosed, when a death occurs, and when it is reported.

COVID-19 transmission in Mohave County has moved up to the medium transmission category according to the CDC Dashboard. ADHS continues to review and audit case/death-related data, and as a result, numbers may fluctuate above or below those previously reported.

The reported cases have generally increased week over week in November.

The ATTACHED Fact Sheet Above in this report shows considerably more detailed information and explanations on the data.

______________________________________________________________________

 Protect yourself and others

• Get Vaccinated
• Wear a mask in areas of substantial or high transmission
• Stay 6 feet away from others
• Avoid crowds and poorly ventilated spaces
• Wash your hands often
• Clean and disinfect high touch surfaces
• Cover coughs and sneezes
• Test to prevent the spread to others
• Monitor your health daily – Be alert for symptoms

 For more detailed information, please visit https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html

Treatment Options

ADHS has launched a new website for treatments in Arizona to complement the current monoclonal antibodies website.

ADHS – Everyone – Monoclonal Antibodies (mAbs) (azdhs.gov)

ADHS – Everyone – Find Treatment (azdhs.gov)

ADHS – Everyone – Antivirals (azdhs.gov)

While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.

Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus-like the virus that causes COVID-19. That’s why mAb treatment may help patients at high risk for severe symptoms or hospitalization.

The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19.

General eligibility information is below.

• Individuals who have tested positive for COVID-19 and are within ten days of onset
• Unvaccinated individuals who have had close contact with a COVID positive person
• Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person
• Each facility has its standards for administering Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.

 Kingman Regional Medical Center (KRMC)

Website:

Seeking Medical Care For Covid-19 | KRMC | Kingman Regional Medical Center (azkrmc.com)

Phone Number: 928-681-8699

Western Arizona Regional Medical Center (WARMC)

Website: https://www.warmc.com/covid-19

Phone number: 928-763- 2273

Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)

Phone number: 928-505-1030

Veklury® (Remdesivir) (FDA approved)

Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body. Veklury® (Remdesivir) is approved for hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.